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Abstract C••ning •f a cDNA fr•m Cry j I•• the sec•nd maj•r a••ergen fr•m Japanese cedar (Crypt•meria j p•nica) p•••en• is described• An is••ated 
Cryj II eDNA contained an open reading frame coding for 514 amino acid residues. The mature Cryj II protein consisted of 388 amino acid residues 
(R's-S433). According to a homology analysis, no amino acid sequence homology was observed between Cryj II and Cryj I, another major allergen. 
But Cryj II showed homology with polygalacturonase (PG) derived from tomato (40% identity) at the amino acid level. The sequence information 
can potentially be used to devise an effective course of immunotherapy for Japanese cedar pollinosis. 
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1. Introduction 
Japanese cedar pollinosis is one of the most important aller- 
gic diseases in Japan. Two major allergens, Cry j I and Cry j 
II, have now been identified in Japanese cedar pollen. Cry j I 
was first purified and identified in 1983 [1]. Cryj II was identi- 
fied in 1990 [2] as an allergen different from Cryj I in molecular 
weight, antigenicity and N-terminal amino acid sequence (10 
residues). Cryj I and Cryj II are present in a pollen extract at 
a ratio of about 4:1, and 24 of 25 patients allergic to Japanese 
cedar pollen showed a positive reaction to Cryj I, while 19 of 
the 25 patients howed a positive reaction to Cry j II by a 
radioallergosorbent test and a skin test [3]. Thus Cryj II is also 
clinically important. Some monoclonal antibodies (mAbs) spe- 
cific for Cryj I or Cryj II have been obtained [3], and enzyme- 
linked immunosorbent assay systems have been established 
specifically determining Cry j I or Cry j II in the crude pollen 
extract [4]. Very recently, Cry j I eDNA was obtained [5,6]. 
However, Cry j II eDNA has not been obtained yet. 
In this report, the eDNA cloning and the deduced amino acid 
sequence of a Cryj II eDNA clone are described. Partial amino 
acid sequences determined on the enzyme-digested Cry j II 
peptides were included in the deduced sequence from the 
cDNA. 
2. Materials and methods 
2.1. Plant materials 
Fresh male flowers were collected from Japanese cedar trees located 
in Okayama, Japan, and stored at -80°C until used. 
2.2. Isolation of Cry j H protein 
Cry j II protein was isolated from Japanese cedar pollen extract by 
affinity chromatography using an mAb specific for Cry j II, N26 [7]. 
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Abbreviations." PVDF, polyvinylidene difluoride; RT-PCR, reverse 
transcription-polymerase chain reaction; RACE, rapid amplification of
eDNA ends; PG, polygalacturonase; TPCK-trypsin, N-tosyl-L-phen- 
ylalanine chloromethyl ketone treated trypsin; mAb, monodonal nti- 
body; CNBr, cyanogen bromide. 
2.3. Analysis of the N-terminal mino acid sequence ofCry j H 
The Cry j II protein was then transferred to a polyvinylidene di- 
fluoride (PVDF) membrane (ProBlot, Applied Biosystems, CA, USA) 
after SDS-PAGE, and was sequenced on a protein sequencer (model 
473A, Applied Biosystems). 
2.4. Preparation of pyridylethylated Cry j H protein 
Pyridylethylated Cryj II protein was prepared to analyze the cysteine 
residues as described previously [8]. 
2.5. Analysis of enzyme-digested Cry j H 
The Cryj II protein was digested with V8 protease (from Staphylo- 
coccus, Sigma, MO, USA), pepsin (from porcine stomach mucosa, 
Sigma) or lysylendopeptidase (from Acromobactor, Seikagaku Corpo- 
ration, Tokyo, Japan) as described previously [9]. The pyridylethylated 
Cry j II protein was digested with N-tosyl-L-phenylalanine chloro- 
methyl ketone treated trypsin (TPCK-trypsin) (from bovine pancreas, 
Sigma; 25/,tg per 1 mg Cryj II at 37°C for 20 h in 0.1 M sodium 
bicarbonate) or lysylendopeptidase, or cleaved with cyanogen bromide 
(CNBr) (Wako Pure Chemical Industries, Osaka, Japan; 6 mg per I mg 
Cryj II in 75% trifluoro acetic acid at room temperature for 20 h). The 
enzyme-digested or CNBr-cleaved peptides of the Cry j II protein or 
the pyridylethylated Cryj II protein were separated on a reversed-phase 
HPLC C18 column (218TP54, Vydac, CA, USA). The amino acid 
sequences of the peptides were determined on the protein sequencer. 
2.6. Analysis of the C-terminal mino acid sequence ofCry j H 
The lysylendopeptidase-digested Cry j II protein was applied to an 
anhydrotrypsin-agarose c lumn (Takara Shuzo, Kyoto, Japan). This 
column has the ability to catch peptide fragments, the C-terminal ends 
of which are either a lysine residue, an arginine residue or an aminoethyl 
derivative of a cysteine residue [10]. The fraction, being passed through 
the column, was collected and separated on a C18 column for amino 
acid sequencing. 
2. 7. Isolation of RNA 
Japanese cedar male flower RNA was isolated according to [11], and 
further purified on a hydroxyapatite (Gigapite, Toa Gosei, Tokyo, 
Japan) column equilibrated with 10 mM sodium phosphate buffer (pH 
6.8), then the RNA was eluted with 300 mM sodium phosphate buffer 
(pH 6.8). 
2.8. Amplification ofCry j H cDNA 
The primers used for reverse transcription-polymerase chain reaction 
(RT-PCR) were synthesized on a DNA synthesizer (model 394, Applied 
Biosystems). Primer-specific DNAs were amplified from 1 /tg RNA 
using a Gene Amp RNA PCR kit (Takara Shuzo) as described previ- 
ously [12]. Cloning of the eDNA terminal regions (3' or 5' end) was 
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performed by rapid amplification of the cDNA ends (RACE) method 
as described previously [13]. 
2.9. Screening and sequencing of PCR products 
The PCR products were examined by Southern blotting. The DNAs 
showing a positive signal were ligated into a sequencing vector, 
pT7Blue (NoVagen, WI, USA). Positive clones were sequenced on a 
DNA sequencer (model 373A, Applied Biosystems). 
3. Results 
Before cloning Cry j II cDNA, the partial amino acid se- 
quences of Cry j II were determined. First, the N-terminal 
amino acid sequence of Cry j II was determined as RK- 
VEHSRHDAINIFNVEKYGAVGDGKH. Second, the Cry j 
II protein or the pyridylethylated Cryj II protein was digested 
with several enzymes, and then the amino acid sequences of the 
resulting peptides were determined. Based on these sequences, 
we synthesized some degenerate s nse and antisense oligonucle- 
otides, and tried RT-PCR on cedar male flower RNA using 
combinations of the synthesized primers (Table 1). Five clones 
having partial Cry j II cDNA were obtained and designated 
CJII-1, CJII-2, CJII-3, CJII-4 and CJII-5 as shown in Fig. IA. 
By combination and rearrangement of the nucleotide sequences 
of the five clones, we obtained a complete sequence of Cryj II 
cDNA having 1790 bp. Considering the amino acid sequence 
analysis, we determined that the open reading frame of Cry j 
II begins from the start codon at position 126-128 and ends at 
the stop codon at position 1668-1670, as shown in boxes in Fig. 
1A. Thus the protein coding region of the Cry j II cDNA 
consisted of 1542 bp coding 514 amino acid residues. As shown 
in Fig. 1B, three possible N-linked glycosylation sites hav- 
ing the characteristic N-X-S/T motif were observed at the 
429-, 460- and 472-asparagine r sidues in the amino acid se- 
quence deduced from Cry j II cDNA. The amino acid se- 
quences of the 26 fragments analyzed are shown underlined as 
amino acid residues. They were completely compatible with the 
corresponding amino acid sequences deduced from the cDNA. 
In Fig. 1B, ATL-5, the peptide fragment obtained by C-termi- 
nal amino acid sequence analysis was located in the last posi- 
tion of the all analyzed sequences. We therefore decided that 
the C-terminal amino acid sequence of Cryj II must be NLSPS. 
From these results, we decided that the Cry j II protein is 
constructed from 388 amino acid residues (Arg46-Ser433). 
No amino acid sequence homology was observed between 
1 
GTTGAAAATGCCTCAGTGCAATCATGCTT 
TCACCTCCCACCGCTACACCTCTCCGATCGGCCGCGATGTTTTCTTCTCTATAGTTGAGTTCGAGACAACTATAGAAAGAATTTTCTTTTATTAAA 
~GC~ATGAAATTCATTGCT~CAATGGC~TTTGTGGCCATGCAATTGATTATAATGGCGG~AG~AGAAGATCAAT~TG~CAAATTATGTTGGA~ 
CJII-4 
AGTGATATCGAACAATATCTTAGATCGAATCGGAGTTTAAGAAAAGTTGAGCATT•TCGTCATGATGCTATCAACATCTTCAATGTGGAAAAATAT 
GGCGCAGTAGGCGATGGAAAGCATGATTGCACTGAGGCATTTTCAACAGCATGGCAAGCTGCATGCAAAAAGCCATCAGCAATGTTGCTTGTGCCA 
CJII-I 
GGCAACAAGAAATTTGTTGTAAACAATTTGTTCTTCAATGGGCCATGTCAACCTCACTTTACTTTTAAGGTAGATGGGATAATAG•TGCGTAC•AA 
AATCCAGCTAGCTGGAAGAATAATAGAATATGGTTGCAGTTTGCTAAACTTACAGGTTTTACTCTAATGGGTAAAGGTGTAATTGATGGGCAAGGA 
AAACAATGGTGGGCTGGCCAATGTAAATGGGTCAATGGACGAGAAATTTGCAACGATCGTGATAGACCAACAGCCATTAAATTCGATTTTTCCACG 
GGTCTGATAATCCAAGGACTGAAACTAATGAACAGCCCCGAATTTCATTTAGTTTTTGGGAATTGTGAGGGAGTAAAAATCATCGGCATTAGTATT 
~JII-2- 
ACGGCACCGAGAGACAGTCCTAACACTGATGGAATTGATATCTTTGCATCTAAAAACTTTCACTTACAAAAGAACACGATAGGAACAGGGGATGAC 
TGCGTCGCTATAGGCACAGGGTCTTCTAATATTGTGATTGAGGATCTGATTTGCGGTCCAGGCCATGGAATAAGTATAGGAAGTCTTGGGAGGGAA 
AA•TCTAGAGCAGAGGTTTCATACGTGCACGTAAATGGGGCTAAATTCATAGACACACAAAATGGATTAAGAATCAAAACATGGCAGGGTGGTTCA 
GGCATGGCAAGCCATATAATTTATGAGAATGTTGAAATGATAAATTCGGAGAACCCCATATTAATAAATCAATTCTACTGCACTTCGGCTTCTGCT 
TGCCAAAAC CAGAGGTCTGCGGTTCAAATCCAAGATGTGACATACAAGAACATACGTGGGACATCAGCAACAGCAGCAGCAATTCAACTTAAGTGC 
CJII-3- 
AGTGACAGTATGCCC TGCAAAGATATAAAGCTAAGTGATATATCTTTGAAGCTTACCTCAGGGAAAATTGCTTCCTGCCTTAATGATAATGCAAAT 
GGATATTTCAGTGGACACGTCATCCCTGCATGCAAGAATTTAAGTCCAAGTGCTAAGCGAAAAGAATCTAAATC CC TAAACACC AAAAACTGTC 
ATGGTTAAAAATATGGGAGCATATGACAAGGGTAACAGAACACGCATATTGTTGGGGTCGAGGCCTCCGAATTGTACAAACAAATGTCATGGTTGC 
CJII-5- 
AGTCCATGTAAGGCCAAGTTAGTTATTGTTCATCGTATTATGCCGCAGGAGTATTATC CTCAGAGGTGGATGTGCAGCCGTCATGGCAAAATCTAC 
1668 
CATC CA~TGAGATAC AT TGAAAC TGTATGTG CTAGTGAATATTC TTGTGGTACAATATTAGAAC TGATATTGAAAATAAATC ATAAATGTTTC T 
AAG GCATTTATAATAGATTATATTAATGGTTCA 
Fig. 1. (A) Nucleotide sequence of Cry j II cDNA. Translation i itiation codon and stop codon are shown in boxes. Nucl¢otide sequences offive 
clones obtained separately by RT-PCR and RACE methods are underlined. 
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1 I0 20 30 40 * 
MAMKF I A P M A F V A M Q L I  I M A A A E D Q S A Q  I MLDSD I E Q Y L R S N R S L R K V  
50 60 70 80 90 
E H S R H D A  I N I F N V E K Y G A V G  D G K H D C T E A F  S T A W Q A A C K K P S A M L L V P  
L-33 L-32 
N-terminal 
100 ii0 120 130 140 
G N K K F V V N N L F F N G P C Q P H F T F K V D G  I I A A Y Q N P A S W K N N R  IWLQFAK 
L-43 
PC-46 
PL-49 
150 160 170 180 190 
L T G F T L M G K G V I  D G Q G K Q W W A G Q C K W V N G R E  I C N D R D R P T A I K F D F S T  
PL-46 PT-13 PL-39 ATL-I 0 
200 210 220 230 240 
GL  I I Q G L K L M N S P E F H L V F G N C  EGVK I IG I  S ITAPRDS PNTDGI  D I FA  
L-58 L-53 
PL-53 
250 260 270 280 
S K N F H L Q K N T  I G T G D D C V A I  GTGS SN IV I  EDL  I C G P G H G I  S IGSLGRE 
L-21 L-60 
PL-V-23 
290 300 310 320 330 
N S R A E V S Y V H V N G A K F  I D T Q N G L R  I K T W Q G G S G M A S H  I I Y E N V E M I N S 
V-47 
PL-V-10 PC-21 
340 350 360 370 380 
E N P I L I N Q F Y C T S A S A C Q N Q R S A V Q I Q D V T Y K N I R G T S A T A A A I Q L K C  
P-16 V-31 
PC-28 PT-29 
390 400 410 420 430 
S D S M P C K D I K L S D I S L K L T S G K I A S C L N D N A N G Y F S G H V I P A C K ~ P  
V-52 
PC-24 ATL-5 
* 440 450 460 470 480 
S A K R K E S K S H K H P K T V M V K N M G A Y D K G ~ R I L L G S R P P ~ N K C H G C  
490 500 510 B 
S P C K A K L V I V H R  I M P Q E Y Y P Q R W M C  SRHGK I YHP  
Fig. 1 (B) Amino acid sequence deduced from Cryj II cDNA. The amino acid sequences underlined were analyzed on an amino acid sequencer after 
being treated as follows. N-terminal, PVDF blotting after SDS-PAGE; ATL, lysylendopeptidase digestion followed by fractionation with anhydro- 
trypsin-agarose column; P, pepsin digestion; L, lysylendopeptidase digestion; V, V8 protease digestion; PT, TPCK-trypsin digestion of pyridylethyl- 
ated Cry j II protein; PC, CNBr cleavage of pyridylethylated Cry j II protein; PL, lysylendpeptidase digestion of pyridylethylated Cry j II protein, 
and PL-V, lysylendpeptidase followed by V8 protease digestion of pyridylethylated Cryj II protein. *The N-terminal (R-46) and the C-terminal (S-433) 
amino acids of the Cry j II protein are indicated with asterisks. The enzyme used and the peptide fraction number are shown together underlined. 
N-linked glycosylation sites are shown in boxes. 
Table 1 
Oligonucleotides u ed to obtain clones of Cryj II cDNA by RT-PCR and RACE methods 
Clones Primers or probes a Sequences b Nucleotide positions 
CJII-1 SP1 5' CAYGAYGCNATHAAYAT 282-298 
AP1 5' GCNGCYTGCCANGC 366-379 
(299 365) P1 5' TTYAAYGTNGARAARTAYGG 300-319 
CJII-2 SP2 5' ATATGGCGCAGTAGGCGATGG 314-334 
AP2 5' TCDATNACDATRTT 921-934 
(335-920) P2 5' TGTTGAAAATGCCTCAGTGC 346-365 
CJII-3 SP3 5' AAGAACACGATAGGAACAGGG 867-887 
AP3 5' TANCCRTTNGCRTTRTCRTT 1359-1378 
(888-1358) P3 5' GTGCCTATAGCGACGCAGTC 890-910 
CJII-4 (dT)~7-adaptor c 5' GACTCGAGTCGACATCGA(T) 17 
AP4 5' TCATGCTTTCCATCGCCTAC 324-343 
(1-323) P4 5' TGTGGAAAAATATGGCGCAG 305-314 
CJII-5 SP4 5' ATCTTTGAAGCTTACCTCAGGG 1319-1340 
(dT)17-adaptor 5' GACTCGAGTCGACATCGA(T) 17 
(1341-1790) P5 5' AAGGCAGGAAGCAATTTT 1341 1358 
aSP, sense primer; AP, antisense primer; P, probe, bGenetic odes used are: N, AGCT; Y, CT; R, AG; H, ATC; D, AGT c) primer for RACE method, 
annealing with a poly(A) tail. 
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1 20 40 60 80 
MAMKFIApMAFVAMQLI IM~EDQSAQIMLDSDIEQYL-RSNRSLRKVEHSRHDAIN IFNVEKYGAVGDGKHDCTEAFST 
++ + + + + + **  ++ * +++++ +++*+++**  ++**  ****  + **+ 
MVIQRNSILLL I I I FASS ISTCRSNVIDDNLFKQVYDNILEQEFAHDFQAYLSYLSKNIESNNNIDKVDKNGIKVINVLSFGA/~GDGKTYDNIAFE~ 
100 120 140 160 
AWQAACKKPSAM-LLVPGNKKFVVNNLFFNGPC•PHFTFKVDGI IAAY•NPASWKNNRIWL•FAKLTGFTLMGKGVIDG•GK•WWAG•CKWVNGREI  
• *++**++++++ ++**  **++++++++*+***++ ++ *+ * ++* ++++*++*+*++*+++ ++++ * *+*+*+*+ **++ ** +*  + 
AWNEACSSRTPV•FVVPKNKNYLLK•ITFSGPCRSSISVKIFGSLEASSKISDYKDRRLWIAFDSV•NLVVGGGGTINGNG•VWWPSSCK-INKSLP 
180 200 220 240 260 
CNDRDR~TAIKFDFSTGL I IQGLKLMNSPEFHLvFGNC~GVKI~GIS ITAPRDS~NTDGIDIFASKNFHLQKNTIGT~DDCVAIGTGSSNIV~EDLI  
* ** ***++* +++* +++**  +*++++*+ *++*++* ++ *+*+ +******+++ +++ +++ +++*******++* +**  *+ ++++ 
C- -RDAPTALTFWNCKNLKVNNLKSKNAQQIHIKFESCTNvvASNLMINASAKSPNTDGVHv•NTQYIQ I•DT I IGTGDDCIS IvSGS•Nv•ATN•T 
280 300 320 340 360 
CGPGHGIS IGSLGRENSRAEVSYVHvNGAKF IDTQNGLRIKTW•GGSGMASHI IYENvEMINSENP•L INQFYCTSASAC•N•RSAV• I•DvTYKNI  
*************++**  * ** * ***********************  **+*  + ****  + + **+*+*  **+++++* +*  ****+++*+*+**  
CGPGHG•••GSLGSGNSEAYVSNvTVNEAK••GAENGVRIKTW•GGSG•ASN•KFLNVEM•DVKY••••D••YCDR•EPCI••FSAV•VKNVVYENI  
380  400 420 440 
RGTSATAAAIQLKCSDSMPCKDIKLSDISLKLTSGKIASCLNDNANGYFSGI•v IPACKNLSPSAKRKESKSf•KHPKT•rMvKNMGAYDK. . .  
+*****  +**+++**+++**++* +++*+* +***  ++ +*++ ++**+*  *++* * + 
KGTSATKVAIKFDCSTNFPCEGI IMENINLVGESGKPSEATCKNVHFNNAEHVTPHCTSLE ISEDEALLYNY 
Fig. 2. Comparison of the deduced amino acid sequences of Cry j II (upper) and Lycopersicon esculentum PG (lower). The amino acid residues 
underlined indicate a mature protein region. *Identical amino acid. +Conservative substitution. 
Cry j II and Cry j I. However, searching the SWISS-PROT 
database revealed that the Cryj II amino acid sequence shares 
a significant homology with polygalacturonases (PGs), espe- 
cially that derived from tomato, Lycopersicon esculentum (40% 
identity, Fig. 2) [14,15], from Zea mays (34% identity) [16,17], 
and that from Oenothera organensis (34% identity) [18]. 
4. Discussion 
As a result of molecular cloning and amino acid sequence 
analysis of Cryj II, we have isolated a eDNA clone coding 514 
amino acid residues. The mature Cry j II protein consisted of 
388 amino acid residues. It was reported that the N-terminal 
amino acid sequence of Cryj II was AINIFNVEKY [2]. How- 
ever, our results howed that the N-terminal amino acid residue 
begins at arginine, located 9 residues before this sequence. This 
difference may be due to different preparation methods. Calcu- 
lating the molecular weight from the deduced amino acid se- 
quence, that of the mature protein (388 residues) was 42.2 kDa 
and that of the precursor protein (514 residues) was 56.6 kDa. 
By SDS-PAGE analysis under reducing conditions, the esti- 
mated molecular weight of the mature protein was 42 kDa, 
which was found to agree with the calculated molecular weight. 
It is likely, therefore, that both the 45 N-terminal amino acid 
residues and the 81 C-terminal amino acid residues are cleaved 
from the precursor protein. It has been reported that Cry j II 
is located in the amyloplast in Japanese cedar pollen [19]. The 
rye-grass allergen, Lolp I was also reported to be located in the 
amyloplast [20]. This allergen is thought o be synthesized in the 
cytosol as a precursor containing a transit peptide (25 amino 
acid residues) that is cleaved after transport of the protein to 
the amyloplast. A similar cleavage may occur after the trans- 
port of precursor Cry j II protein to the amyloplast. 
Because Cry j II has a homology with PGs, we assessed the 
PG activity of the Cry j II protein. We found that it has enzy- 
matic activity that hydrolyzes pectin (Otsuki, manuscript in 
preparation), although the physiological role of Cryj II in the 
amylopla~t is still unknown. 
PGs of plant origin have not been reported to cause polli- 
nosis, although the PG from Aspergillus niger has been reported 
to cause allergic asthma [21]. It would be interesting to examine 
the immunoreactive sites of Cryj II and compare them with the 
active sites in the PGs. 
In many clinical reports [22], a majority of patients ensitive 
to Japanese cedar pollen also react to pollen allergens from 
plants botanically related to the Japanese cedar. When the 
primary structures of those allergens are determined, the se- 
quence similarities between the allergens and Cry j I or Cry j 
II will be clarified. A good knowledge of the immunoreactive 
sites responsible for the cross reactions will be beneficial in the 
treatment of allergic diseases. The Cry j II sequence informa- 
tion revealed in this report can potentially be used to devise an 
effective course of immunotherapy for Japanese cedar polli- 
nosis. 
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